Exogenous reinfection of tuberculosis in a low-burden area.

Published

Journal Article

PURPOSE: Recurrence of tuberculosis (TB) can be the consequence of relapse or exogenous reinfection. The study aimed to assess the factors associated with exogenous TB reinfection. METHODS: Prospective cohort study based on the TB database, maintained at the Division of Infectious Diseases, Luigi Sacco Hospital (Milan, Italy). Time period: 1995-2010. INCLUSION CRITERIA: (1) ≥2 episodes of culture-confirmed TB; (2) cure of the first episode of TB; (3) availability of one Mycobacterium tuberculosis isolate for each episode. Genotyping of the M. tuberculosis strains to differentiate relapse and exogenous reinfection. Logistic regression analysis was used to assess the influence of risk factors on exogenous reinfections. RESULT: Of the 4682 patients with TB, 83 were included. Of these, exogenous reinfection was diagnosed in 19 (23 %). It was independently associated with absence of multidrug resistance at the first episode [0, 10 (0.01-0.95), p = 0.045] and with prolonged interval between the first TB episode and its recurrence [7.38 (1.92-28.32) p = 0.004]. However, TB relapses occurred until 4 years after the first episode. The risk associated with being foreign born, extrapulmonary site of TB, and HIV infection was not statistically significant. In the relapse and re-infection cohort, one-third of the patients showed a worsened drug resistance profile during the recurrent TB episode. CONCLUSIONS: Exogenous TB reinfections have been documented in low endemic areas, such as Italy. A causal association with HIV infection could not be confirmed. Relapses and exogenous reinfections shared an augmented risk of multidrug resistance development, frequently requiring the use of second-line anti-TB regimens.

Full Text

Duke Authors

Cited Authors

  • Schiroli, C; Carugati, M; Zanini, F; Bandera, A; Di Nardo Stuppino, S; Monge, E; Morosi, M; Gori, A; Matteelli, A; Codecasa, L; Franzetti, F

Published Date

  • December 2015

Published In

Volume / Issue

  • 43 / 6

Start / End Page

  • 647 - 653

PubMed ID

  • 25754899

Pubmed Central ID

  • 25754899

Electronic International Standard Serial Number (EISSN)

  • 1439-0973

Digital Object Identifier (DOI)

  • 10.1007/s15010-015-0759-9

Language

  • eng

Conference Location

  • Germany